Indivduos com sobrepeso (IMC entre 25 e 29,9) e patologias relacionadas, quando a perda de peso favorece a gesto dessas condies
Soft tissue injuries, joint pain, post-surgical recovery, chronic inflammation, slow healing, athletic recovery, and patients who want a two-peptide approach to accelerate their body's repair processes
Grams 2 Key Points Compared with glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with a lower risk of kidney failure among individuals with type 2 diabetes
Medicare generally does not cover weightloss use
The compound is frequently referred to as a triple-hormone-receptor agonist retatrutide because it simultaneously targets: GLP-1 receptor pathways Glucagon receptor pathways Glucose-dependent insulinotropic polypeptide receptor pathways This triple agonist mechanism differentiates retatrutide from earlier GLP-1 receptor agonist compounds and other research peptides currently studied for obesity and metabolic dysfunction
Inzucchi SE, Bergenstal RM, Buse JB et al (2015) Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes